X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (68) 68
hematology (38) 38
index medicus (29) 29
female (23) 23
male (20) 20
multiple myeloma (20) 20
middle aged (19) 19
multiple-myeloma (19) 19
aged (18) 18
multiple myeloma - immunology (18) 18
adult (15) 15
multiple myeloma - therapy (15) 15
t-lymphocytes - immunology (15) 15
oncology (14) 14
activation (10) 10
cancer (10) 10
cell biology (10) 10
immunology (10) 10
immunotherapy (10) 10
multiple myeloma - pathology (10) 10
t cells (10) 10
zoledronic acid (10) 10
aged, 80 and over (9) 9
dendritic cells (9) 9
expression (9) 9
lymphocytes (9) 9
lymphoma (9) 9
stem-cell transplantation (9) 9
t-cells (9) 9
treatment outcome (9) 9
chemotherapy (8) 8
animals (7) 7
follow-up studies (7) 7
lymphocyte activation - immunology (7) 7
receptors, antigen, t-cell, gamma-delta - immunology (7) 7
survival (7) 7
t lymphocytes (7) 7
apoptosis (6) 6
diphosphonates - pharmacology (6) 6
further section (6) 6
immune-responses (6) 6
leukemia (6) 6
leukemia, lymphocytic, chronic, b-cell - drug therapy (6) 6
lymphocyte activation (6) 6
mevalonate pathway (6) 6
multiple myeloma - drug therapy (6) 6
multiple myeloma - mortality (6) 6
survival analysis (6) 6
transplantation (6) 6
vγ9vδ2 t cells (6) 6
abridged index medicus (5) 5
antineoplastic combined chemotherapy protocols - administration & dosage (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
cells, cultured (5) 5
chronic lymphocytic leukemia (5) 5
chronic lymphocytic-leukemia (5) 5
colony-stimulating factor (5) 5
cyclophosphamide (5) 5
cytotoxicity (5) 5
cytotoxicity, immunologic (5) 5
dendritic cells - immunology (5) 5
doxorubicin (5) 5
high-dose chemotherapy (5) 5
imidazoles - pharmacology (5) 5
myeloma (5) 5
signal transduction (5) 5
t-lymphocyte subsets - immunology (5) 5
t-lymphocytes, regulatory - immunology (5) 5
transplantation, autologous (5) 5
transplantation, homologous (5) 5
trial (5) 5
γδ t cells (5) 5
adaptive immunity (4) 4
antibodies, monoclonal (4) 4
bone marrow (4) 4
bone-marrow (4) 4
bone-marrow transplantation (4) 4
breast cancer (4) 4
care and treatment (4) 4
case-control studies (4) 4
cells (4) 4
combined modality therapy (4) 4
diagnosis (4) 4
drug administration schedule (4) 4
fludarabine (4) 4
idiotype vaccination (4) 4
immunity, cellular (4) 4
immunophenotyping (4) 4
interleukin-2 - pharmacology (4) 4
leukemia, lymphocytic, chronic, b-cell - pathology (4) 4
lymphocyte activation - drug effects (4) 4
lymphocytes - immunology (4) 4
medicine, research & experimental (4) 4
mice (4) 4
monocytes - immunology (4) 4
multiple myeloma - blood (4) 4
nitric-oxide (4) 4
p-glycoprotein (4) 4
proteins (4) 4
stem cell transplantation (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 03/2007, Volume 356, Issue 11, pp. 1110 - 1120
Journal Article
Journal of Experimental and Clinical Cancer Research, ISSN 1756-9966, 11/2018, Volume 37, Issue 1, pp. 286 - 20
Journal Article
BLOOD, ISSN 0006-4971, 10/2015, Volume 126, Issue 16, pp. 1921 - 1924
Journal Article
Frontiers in Immunology, ISSN 1664-3224, 06/2018, Volume 9, p. 1492
Vγ9Vδ2 T cells are non-conventional T cells with a natural inclination to recognize and kill cancer cells. Malignant B cells, including myeloma cells, are... 
Bone marrow | Immune suppression | Immune checkpoints | Vγ9Vδ2 T cells | Multiple myeloma | multiple myeloma | immune suppression | bone marrow | immune checkpoints
Journal Article
Frontiers in Immunology, ISSN 1664-3224, 06/2018, Volume 9, p. 1246
Journal Article
Journal of Cellular and Molecular Medicine, ISSN 1582-1838, 12/2010, Volume 14, Issue 12, pp. 2803 - 2815
It is unknown whether zoledronic acid (ZA) at clinically relevant doses is active against tumours not located in bone. Mice transgenic for the activated ErbB‐2... 
tumour microenvironment | tumour‐associated macrophages | mevalonate pathway | zoledronic acid | angiogenesis | Zoledronic acid | Angiogenesis | Tumour-associated macrophages | Tumour microenvironment | Mevalonate pathway | MEDICINE, RESEARCH & EXPERIMENTAL | STIMULATION | tumour-associated macrophages | CELL-ADHESION | ANTITUMOR-ACTIVITY | CANCER | CELL BIOLOGY | BISPHOSPHONATES | NITRIC-OXIDE | AMERICAN-SOCIETY | T-CELLS | TRANSGENIC MICE | Neovascularization, Pathologic | Imidazoles - administration & dosage | NF-kappa B - metabolism | Vascular Endothelial Growth Factor A - metabolism | Antineoplastic Agents - administration & dosage | Interferon-gamma - metabolism | Nitric Oxide Synthase - genetics | Protein Prenylation | Interleukin-10 - metabolism | Female | Antineoplastic Agents - pharmacology | Macrophages - immunology | Nitric Oxide - biosynthesis | Mammary Neoplasms, Animal - immunology | Mammary Glands, Animal - pathology | Mice, Transgenic | Diphosphonates - administration & dosage | Imidazoles - pharmacology | Mevalonic Acid - metabolism | Macrophages - metabolism | Mammary Neoplasms, Animal - pathology | Animals | Metabolic Networks and Pathways | Genes, erbB-2 | Mammary Neoplasms, Animal - metabolism | Macrophages - drug effects | Mammary Neoplasms, Animal - drug therapy | Mice | Mice, Inbred BALB C | Cell Transformation, Neoplastic - drug effects | Nitric Oxide - metabolism | Diphosphonates - pharmacology | Interleukin | Bone tumors | Metastasis | Macrophages | Carcinogenesis | Vascularization | Carcinogens | Mevalonic acid | Lymphocytes | Vascular endothelial growth factor | Growth factors | Translocation | NF-κB protein | Phenotypes | Dendritic cells | ErbB protein | Transgenic mice | Breast cancer | Nuclear transport | Nitric-oxide synthase | Acids | Nitric oxide | Interferon | Laboratory animals | Tumors | Peritoneum | Index Medicus
Journal Article
Frontiers in Oncology, ISSN 2234-943X, 2018, Volume 8, p. 508
The advent of immune checkpoint (ICP) blockade has introduced an unprecedented paradigm shift in the treatment of cancer. Though very promising, there is still... 
Tumor vaccination | Immune checkpoint blockade | Vγ9Vδ2 T cells | Immunotherapy | Multiple myeloma | multiple myeloma | tumor vaccination | immunotherapy | immune checkpoint blockade
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2013, Volume 8, Issue 4, p. e60975
Durable tumor cell eradication by chemotherapy is challenged by the development of multidrug-resistance (MDR) and the failure to induce immunogenic cell death.... 
ADAPTIVE IMMUNITY | BISPHOSPHONATES | ACTIVATION | MEDIATED DRUG-RESISTANCE | MULTIDISCIPLINARY SCIENCES | NITRIC-OXIDE | ANTITUMOR-ACTIVITY | EXPRESSION | CHEMOTHERAPY | MODULATION | P-GLYCOPROTEIN | Prenylation - drug effects | Drug Resistance, Multiple - drug effects | Humans | ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism | Cell Death - immunology | ras Proteins - metabolism | Extracellular Signal-Regulated MAP Kinases - metabolism | Terpenes - metabolism | rho-Associated Kinases - metabolism | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | CD8-Positive T-Lymphocytes - metabolism | Dendritic Cells - drug effects | Cell Death - drug effects | Dendritic Cells - metabolism | Phagocytosis - drug effects | Imidazoles - pharmacology | Down-Regulation - drug effects | Mevalonic Acid - metabolism | Signal Transduction - drug effects | Models, Biological | CD8-Positive T-Lymphocytes - drug effects | Cell Line, Tumor | ATP Binding Cassette Transporter, Sub-Family B | Protein Kinase Inhibitors - pharmacology | Cholesterol - biosynthesis | Diphosphonates - pharmacology | Doxorubicin - pharmacology | Drug Resistance, Neoplasm - drug effects | Drug Screening Assays, Antitumor | Drug resistance in microorganisms | Anthracyclines | Immune response | Dendritic cells | Biochemistry | T cells | Investigations | Prevention | Chemotherapy | Cell death | Cancer cells | Health aspects | Cancer | Drugs | Toxicity | CD8 antigen | Lung cancer | Cytotoxicity | Oncology | Lymphocytes T | Drug resistance | Kinases | Doxorubicin | Recruitment | Proteins | Signal transduction | Mevalonic acid | Lymphocytes | Zoledronic acid | P-Glycoprotein | Medical research | Hematology | Mortality | Glycoprotein | RhoA protein | Breast cancer | Cholesterol | Studies | Signaling | Acids | Immunogenicity | Hypoxia | Apoptosis
Journal Article
European Journal of Immunology, ISSN 0014-2980, 07/2012, Volume 42, Issue 7, pp. 1668 - 1676
Journal Article
Journal Article